Israel is involved in the EPTRI project in the Thematic Research Platforms on “Developmental Pharmacology” and “Paediatric Medicines Formulation and Medical Devices” with the participation of Technion-Israel Institute of Technology (TECHNION) for their technological expertise in drug study programs and development of formulations targeting brain disorders.
The Chief Scientist of the Israeli Ministry of Health granted the official support to EPTRI by signing an expression of political support letter (EoS) on the 3rd of June 2019.
The main Israeli Institutes have expressed their interest in EPTRI and organized themselves into the Israeli Core Facility (ICF). All of them will be part of the new establishing Israeli National node. More details on these Institutions are provided below: